Cargando…

Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease

A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss. Furosemide to treat fluid retention markedly decreased extracellular water compared with intracellular water, but the addition of tolvaptan equa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagayama, Izumi, Masuda, Takahiro, Nakagawa, Saki, Murakami, Takuya, Ohara, Ken, Matsuoka, Ryo, Kobayashi, Takahisa, Maeshima, Akito, Akimoto, Tetsu, Saito, Osamu, Muto, Shigeaki, Nagata, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599930/
https://www.ncbi.nlm.nih.gov/pubmed/30713322
http://dx.doi.org/10.2169/internalmedicine.2174-18
_version_ 1783431016146272256
author Nagayama, Izumi
Masuda, Takahiro
Nakagawa, Saki
Murakami, Takuya
Ohara, Ken
Matsuoka, Ryo
Kobayashi, Takahisa
Maeshima, Akito
Akimoto, Tetsu
Saito, Osamu
Muto, Shigeaki
Nagata, Daisuke
author_facet Nagayama, Izumi
Masuda, Takahiro
Nakagawa, Saki
Murakami, Takuya
Ohara, Ken
Matsuoka, Ryo
Kobayashi, Takahisa
Maeshima, Akito
Akimoto, Tetsu
Saito, Osamu
Muto, Shigeaki
Nagata, Daisuke
author_sort Nagayama, Izumi
collection PubMed
description A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss. Furosemide to treat fluid retention markedly decreased extracellular water compared with intracellular water, but the addition of tolvaptan equally decreased both with a greater diuretic response than furosemide alone. Furthermore, tolvaptan administration increased the plasma colloid osmotic pressure, which might facilitate the shift of fluid from the extravascular space to the intravascular space. This is the first case showing different effects on the fluid distribution between furosemide and additional tolvaptan in the same patient.
format Online
Article
Text
id pubmed-6599930
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-65999302019-07-01 Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease Nagayama, Izumi Masuda, Takahiro Nakagawa, Saki Murakami, Takuya Ohara, Ken Matsuoka, Ryo Kobayashi, Takahisa Maeshima, Akito Akimoto, Tetsu Saito, Osamu Muto, Shigeaki Nagata, Daisuke Intern Med Case Report A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss. Furosemide to treat fluid retention markedly decreased extracellular water compared with intracellular water, but the addition of tolvaptan equally decreased both with a greater diuretic response than furosemide alone. Furthermore, tolvaptan administration increased the plasma colloid osmotic pressure, which might facilitate the shift of fluid from the extravascular space to the intravascular space. This is the first case showing different effects on the fluid distribution between furosemide and additional tolvaptan in the same patient. The Japanese Society of Internal Medicine 2019-02-01 2019-06-01 /pmc/articles/PMC6599930/ /pubmed/30713322 http://dx.doi.org/10.2169/internalmedicine.2174-18 Text en Copyright © 2019 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Nagayama, Izumi
Masuda, Takahiro
Nakagawa, Saki
Murakami, Takuya
Ohara, Ken
Matsuoka, Ryo
Kobayashi, Takahisa
Maeshima, Akito
Akimoto, Tetsu
Saito, Osamu
Muto, Shigeaki
Nagata, Daisuke
Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease
title Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease
title_full Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease
title_fullStr Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease
title_full_unstemmed Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease
title_short Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease
title_sort different effects on fluid distribution between tolvaptan and furosemide in a liver cirrhosis patient with chronic kidney disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599930/
https://www.ncbi.nlm.nih.gov/pubmed/30713322
http://dx.doi.org/10.2169/internalmedicine.2174-18
work_keys_str_mv AT nagayamaizumi differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT masudatakahiro differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT nakagawasaki differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT murakamitakuya differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT oharaken differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT matsuokaryo differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT kobayashitakahisa differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT maeshimaakito differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT akimototetsu differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT saitoosamu differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT mutoshigeaki differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease
AT nagatadaisuke differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease